TGA Approval

TEPEZZA teprotumumab 500 mg injection powder vial (444610)

ARTG ID

444610

ARTG Name

TEPEZZA teprotumumab 500 mg injection powder vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

March 27, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

Ingredient Name

teprotumumab

Empowering clinical research with data-driven insights and AI-powered tools.

TEPEZZA teprotumumab 500 mg injection powder vial (444610) - TGA 批准文号 | MedPath